Anthony Daniels

With the peak of summer approaching, Vanderbilt researchers will discuss innovative research on melanoma and how new insights could lead to less toxic treatments and better outcomes for patients. “Toward a Cure for Melanoma” will take place on Tuesday, July 27, at noon CT. Read More

Two Vanderbilt Eye Institute physicians have been selected as Emerging Vision Scientists by the Alliance for Eye and Vision Research (AEVR). Read More

Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology. Read More

Sometimes saying thank you just isn’t enough. Read More

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read More

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read More